Collegium Pharmaceutical, Inc. , a specialty pharmaceutical company, develops and commercializes medicines for pain management.
Collegium Pharmaceutical stock last closed at $37.19, down 1.14% from the previous day, and has increased 56.85% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.95 percentage points. Collegium Pharmaceutical stock is currently +77.52% from its 52-week low of $20.95, and -9.18% from its 52-week high of $40.95.
There are currently 32.21M COLL shares outstanding. The market capitalization of COLL is $1.20B. In the past 24 hours, 198,967 COLL shares were traded.
How to Buy Collegium Pharmaceutical Stock
Not sure how to invest in Collegium Pharmaceutical stock? Here's how.
Choose where to buy Collegium Pharmaceutical stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Collegium Pharmaceutical stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit funds into your brokerage account: Choose your payment method and add your information.
Research Collegium Pharmaceutical stock: The Collegium Pharmaceutical ticker symbol is COLL. Is Collegium Pharmaceutical stock a good investment? Should you buy shares of COLL? How do COLL's underlying business fundamentals look? Do top analysts think Collegium Pharmaceutical is a good buy? Why has COLL's stock price moved recently? (Hint: Our stock research website can help you evaluate if COLL is a good stock to buy).
Execute your COLL trade: Decide if you will purchase COLL shares at the current market price or use a limit order to purchase COLL stock at a specific price.
Track your investment in COLL: Create a watchlist to get the latest news on your position in Collegium Pharmaceutical stock.
Step 1: Choose where to buy Collegium Pharmaceutical stock
You need an online brokerage account to access the NASDAQ market and buy COLL stock.
A brokerage account is an investment account that enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you are able to invest in COLL stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Collegium Pharmaceutical stock
After you have chosen the best place to buy Collegium Pharmaceutical stock, it's crucial to analyze their stock prior to buying, so you can wrap your head around the risk as well as the upside.
Collegium Pharmaceutical quick stats
COLL Price
$37.19
1w %
-3.3%
1y %
56.85%
5y %
244.03%
P/E
12.27x
P/B
5.53x
P/S
2.09x
PEG
0.41x
Revenue
$576.65M
Earnings
$99.89M
Fore. Rev. Growth
8.16%
Fore. Earn. Growth
29.76%
Market Cap
$1.20B
Next Earnings
Nov 5, 2024
Next Dividend
N/A
Fundamentals of COLL
WallStreetZen was built to help everyday investors do more accurate fundamental analysis.
Last year, COLL earnings were $99.89M. During the last three year, COLL's earnings have increased by -14.87% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 11.24%.
Last year, COLL revenue was $576.65M. Over the last five year, COLL's revenue has gone up by 14.49% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 19.54%.
No, Collegium Pharmaceutical doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your COLL trade
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually fine for most investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a specific price limit, use a limit order.
Press the Open button and eToro will execute the order.
If you require additional info about buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Collegium Pharmaceutical share?
As of Sep 6, 2024, it costs $37.19 to buy one share of Collegium Pharmaceutical stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.269 shares of COLL.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.